Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Drug Resistance

  Free Subscription


2 Antimicrob Agents Chemother
1 Antivir Ther
1 Clin Infect Dis
1 Emerg Infect Dis
1 Infect Control Hosp Epidemiol
4 Int J Antimicrob Agents
11 J Antimicrob Chemother
2 J Clin Microbiol
1 J Infect Chemother
4 J Med Microbiol
1 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antimicrob Agents Chemother

  1. MISHRA NN, Lew C, Abdelhady W, Lapitan CK, et al
    Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant S. aureus: In vitro, Ex vivo and In vivo Metrics.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0164921. doi: 10.1128/AAC.01649.
    PubMed         Abstract available

  2. ANAHTAR MN, Bramante JT, Xu J, Desrosiers LA, et al
    Prediction of antimicrobial resistance in clinical Enterococcus faecium isolates using a rules-based analysis of whole genome sequences.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0119621. doi: 10.1128/AAC.01196.
    PubMed         Abstract available

    Antivir Ther

  3. JIA J, Shang J, Tang H, Jiang J, et al
    Long-term outcomes in Chinese patients with chronic hepatitis B receiving nucleoside/nucleotide analogue therapy in real-world clinical practice: 5-year results from the EVOLVE study.
    Antivir Ther. 2020 Oct 22. doi: 10.3851/IMP3372.
    PubMed         Abstract available

    Clin Infect Dis

  4. HACKETT S, Teasdale CA, Pals S, Muttiti A, et al
    Drug Resistance Mutations Among South African Children Living With HIV on WHO-recommended ART Regimens.
    Clin Infect Dis. 2021;73:e2217-e2225.
    PubMed         Abstract available

    Emerg Infect Dis

  5. VIANA AS, Nunes Botelho AM, Moustafa AM, Boge CLK, et al
    Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus Associated with Bacteremia and Monocyte Evasion, Rio de Janeiro, Brazil.
    Emerg Infect Dis. 2021;27:2825-2835.
    PubMed         Abstract available

    Infect Control Hosp Epidemiol

  6. LIN G, Tseng KK, Gatalo O, Martinez DA, et al
    Cost-effectiveness of carbapenem-resistant Enterobacteriaceae (CRE) surveillance in Maryland.
    Infect Control Hosp Epidemiol. 2021 Oct 22:1-9. doi: 10.1017/ice.2021.
    PubMed         Abstract available

    Int J Antimicrob Agents

  7. BOAS DO PRADO GV, Mendes ET, Martins RCR, Perdigao-Neto LV, et al
    Phenotypic and genotypic characteristics of a Carbapenem-resistant Serratia marcescens cohort and outbreak: describing an opportunistic pathogen.
    Int J Antimicrob Agents. 2021 Oct 26:106463.
    PubMed         Abstract available

  8. LAI CC, Yu WL
    Klebsiella pneumoniae Harboring Carbapenemase Genes in Taiwan: Its Evolution over 20 Years, 1998-2019.
    Int J Antimicrob Agents. 2021;58:106354.
    PubMed         Abstract available

  9. DELORY T, Gravier S, Pluart DL, Gaube G, et al
    Temocillin versus carbapenems for urinary tract infection due to ESBL-producing Enterobacteriaceae: a multicenter matched case-control study.
    Int J Antimicrob Agents. 2021 May 14:106361.
    PubMed         Abstract available

  10. ANTONELLO RM, Di Bella S, Betts J, La Ragione R, et al
    Zidovudine in synergistic combination with fosfomycin: an in vitro and in vivo evaluation against multidrug-resistant Enterobacterales.
    Int J Antimicrob Agents. 2021;58:106362.
    PubMed         Abstract available

    J Antimicrob Chemother

  11. GUILLOTEAU H, Pradalier C, Roman VL, Bellanger X, et al
    Identification of antibiotics triggering the dissemination of antibiotic resistance genes by SXT/R391 elements using a dedicated high-throughput whole-cell biosensor assay.
    J Antimicrob Chemother. 2021 Oct 21. pii: 6407543. doi: 10.1093.
    PubMed         Abstract available

  12. WATERA C, Ssemwanga D, Namayanja G, Asio J, et al
    HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
    J Antimicrob Chemother. 2021;76:2407-2414.
    PubMed         Abstract available

  13. MARCELIN AG, Charpentier C, Bellecave P, Abdi B, et al
    Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
    J Antimicrob Chemother. 2021;76:2400-2406.
    PubMed         Abstract available

  14. TAYLOR E, Bal AM, Balakrishnan I, Brown NM, et al
    A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK.
    J Antimicrob Chemother. 2021;76:2428-2436.
    PubMed         Abstract available

  15. MARTIN C, Gracias S, Charpentier C, Descamps D, et al
    HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravir.
    J Antimicrob Chemother. 2021;76:2306-2309.
    PubMed         Abstract available

  16. ROSSETTI B, Fabbiani M, Di Carlo D, Incardona F, et al
    Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: results from a European multi-cohort study.
    J Antimicrob Chemother. 2021;76:2394-2399.
    PubMed         Abstract available

  17. GILL CM, Abdelraouf K, Oota M, Nakamura R, et al
    Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models.
    J Antimicrob Chemother. 2021;76:2615-2621.
    PubMed         Abstract available

  18. MAMA OM, Aspiroz C, Lozano C, Ruiz-Ripa L, et al
    Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.
    J Antimicrob Chemother. 2021;76:2519-2527.
    PubMed         Abstract available

  19. ROYER G, Poirel L, La Combe B, Clermont O, et al
    Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:2736-2737.

  20. PALACE SG, Fryling KE, Li Y, Wentworth AJ, et al
    Identification of bile acid and fatty acid species as candidate rapidly bactericidal agents for topical treatment of gonorrhoea.
    J Antimicrob Chemother. 2021;76:2569-2577.
    PubMed         Abstract available

  21. BANGALEE A, Hans L, Steegen K
    Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa.
    J Antimicrob Chemother. 2021;76:2659-2665.
    PubMed         Abstract available

    J Clin Microbiol

  22. CHU SV, Vu ST, Nguyen HM, Le NT, et al
    Fast and sensitive real-time PCR detection of major antiviral drug-resistance mutations in chronic hepatitis B patients using a predesigned panel of Locked-Nucleic-Acid TaqMan probes.
    J Clin Microbiol. 2021 Jul 28:JCM0093621. doi: 10.1128/JCM.00936.
    PubMed         Abstract available

  23. IWAO Y, Mori S, Ato M, Nakata N, et al
    Simultaneous Determination of Mycobacterium leprae Drug Resistance and Single-Nucleotide Polymorphism Genotype by Use of Nested Multiplex PCR with Amplicon Sequencing.
    J Clin Microbiol. 2021;59:e0081421.
    PubMed         Abstract available

    J Infect Chemother

  24. RESENDIZ-SHARPE A, Merckx R, Verweij PE, Maertens J, et al
    Stable prevalence of triazole-resistance in Aspergillus fumigatus complex clinical isolates in a Belgian tertiary care center from 2016 to 2020.
    J Infect Chemother. 2021;27:1774-1778.
    PubMed         Abstract available

    J Med Microbiol

  25. BURGESS SA, Cookson AL, Brousse L, Ortolani E, et al
    The epidemiology of AmpC-producing Escherichia coli isolated from dairy cattle faeces on pasture-fed farms.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available

  26. LITVINOV V, Makarova M, Kudlay D, Nikolenko N, et al
    In vitro activity of bedaquiline against Mycobacterium avium complex.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available

  27. CHIDEBELU PE, Nweze EI, Meis JF, Cogliati M, et al
    Multi-locus sequence typing reveals genotypic similarity in Nigerian Cryptococcus neoformans AFLP1/VNI of environmental and clinical origin.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available

  28. DALLMAN TJ, Charles H, Prochazka M, Sinka K, et al
    Emergence of novel strains of Shigella flexneri associated with sexual transmission in adult men in England, 2019-2020.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available

    PLoS One

  29. MAZZANTI S, Brescini L, Morroni G, Orsetti E, et al
    Candidemia in intensive care units over nine years at a large Italian university hospital: Comparison with other wards.
    PLoS One. 2021;16:e0252165.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  30. ANGST DC, Tepekule B, Sun L, Bogos B, et al
    Comparing treatment strategies to reduce antibiotic resistance in an in vitro epidemiological setting.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.